SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-025915
Filing Date
2024-03-05
Accepted
2024-03-05 16:12:11
Documents
1
Period of Report
2024-03-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8903
  Complete submission text file 0000950170-24-025915.txt   10331
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Lamothe Jeffrey G. (Reporting) CIK: 0001679967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37746 | Film No.: 24720478